Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
19.42
+0.10 (0.52%)
At close: Nov 13, 2026, 4:00 PM EST
19.47
+0.05 (0.26%)
After-hours: Nov 13, 2026, 7:30 PM EST

Vor Biopharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-147.71-341.94-121.19-126.04-93.42-69.02
Net Income
1,354-695.98-116.91-117.86-92.09-70.13
Earnings Per Share
30.51-70.50-34.03-35.08-46.57-41.95
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
481.55455.2191.93137.18230.25207.47
Total Debt
2.81331.8335.6638.9118.01
Net Cash (Debt)
478.74452.2160.1101.52191.33189.46
Net Cash Growth
185.98%652.48%-40.80%-46.94%0.99%526.38%
Net Cash Per Share
10.7945.8117.4930.2296.75113.33

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-119.17-142.71-99.66-100.29-85.14-69.14
Capital Expenditures
-0.51-0.94-0.23-1.07-8.46-3.89
Free Cash Flow
-119.68-143.65-99.89-101.36-93.61-73.04
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.